XORTX Therapeutics Inc (TSE:XRTX) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
XORTX Therapeutics Inc. has successfully closed a $1.5 million registered direct offering and concurrent private placement. The company plans to use the proceeds for working capital and general corporate purposes. This financial maneuver reflects XORTX’s ongoing efforts to advance its innovative therapies for kidney disease.
For further insights into TSE:XRTX stock, check out TipRanks’ Stock Analysis page.